Price adjustments for 4,568 drug items that would decrease drug expenditure for the National Health Insurance (NHI) program by NT$5.53 billion (US$174.45 million) are to go into effect on April 1, the Ministry of Health and Welfare said yesterday.
National Health Insurance Administration National Health Insurance Dispute Mediation Committee Director-General Huang Yu-wen (黃育文) said this year marked the least number of drugs undergoing price adjustment since the implementation of the Drug Expenditure Target program in 2013.
Huang said that 4,568 drugs are to see price adjustments, with the majority, 4,551, to see a price decrease, and 17 to be increased, for a 2.8 percent adjustment range.
Photo: Chiu Chih-jou, Taipei Times
Huang said that drugs for cardiovascular diseases, nerve systems and general anti-infection drugs are to see the most significant adjustments.
The drug Irinotecan Hydrochloride Trihydrate, used to treat colorectal cancer, is to see prices go down by 35 percent from NT$2,504 a vial to NT$1,623 a vial, while Letero Film Coating Tablet, used to treat breast cancer, is to drop 28 percent, from NT$36.6 per tablet to NT$26.5, Huang said.
Bentyline Granulues “Johnson,” tablets. used to treat gastric and duodenal ulcers, had decreased by 27 percent from NT$36.4 to NT$26.6 per tablet.
Dualpress tablets containing Amlodipine besylate/Atorvastatin calcium that are used to treat myocardial infarctions and antiemetics have increased by 20 percent and 19 percent respectively, Huang said.
Huang said the NHI program makes price adjustments annually and considers the number of drugs being adjusted for and the rates of price adjustment to ensure that base prices are not overly impacted.
Pharmaceutical companies that experience profit deceres due to the price adjustments should notify the NHIA within two weeks and make suggestions, as stated by Article 34 of the Regulations for Payout for National Health Insurance Drug Payout Items (全民健康保險藥物給付項目及支付標準), she said.
The NT$5.53 billion conserved by the price adjustments would go toward researching and developing new medical products that share the same dosage quantity, properties and dosage form, she said.
She said that such a development could help bring down prices for generic drugs and allow the government to shift more resources to new drugs that are still protected by patents.
POLAM KOPITIAM CASE: Of the two people still in hospital, one has undergone a liver transplant and is improving, while the other is being evaluated for a liver transplant A fourth person has died from bongkrek acid poisoning linked to the Polam Kopitiam (寶林茶室) restaurant in Taipei’s Far Eastern Sogo Xinyi A13 Department Store, the Ministry of Health and Welfare said yesterday, as two other people remain seriously ill in hospital. The first death was reported on March 24. The man had been 39 years old and had eaten at the restaurant on March 22. As more cases of suspected food poisoning involving people who had eaten at the restaurant were reported by hospitals on March 26, the ministry and the Taipei Department of Health launched an investigation. The Food and
A fourth person has died in a food poisoning outbreak linked to the Xinyi (信義) branch of Malaysian restaurant chain Polam Kopitiam (寶林茶室) in Taipei, Deputy Minister of Health and Welfare Victor Wang (王必勝) said on Monday. It was the second fatality in three days, after another was announced on Saturday. The 40-year-old woman experienced multiple organ failure in the early hours on Monday, and the family decided not to undergo emergency resuscitation, Wang said. She initially showed signs of improvement after seeking medical treatment for nausea, vomiting and diarrhea, but her condition worsened due to an infection, he said. Two others who
MEDICAL: The bills would also upgrade the status of the Ethical Guidelines Governing the Research of Human Embryos and Embryonic Stem Cell Research to law The Executive Yuan yesterday approved two bills to govern regenerative medicine that aim to boost development of the field. Taiwan would reach an important milestone in regenerative medicine development with passage of the regenerative medicine act and the regenerative medicine preparations ordinance, which would allow studies to proceed and treatments to be developed, Deputy Minister of Health and Welfare Victor Wang (王必勝) told reporters at a news conference after a Cabinet meeting. Regenerative treatments have been used for several conditions, including cancer — by regenerating blood cells — and restoring joint function in soft tissue, Wang said. The draft legislation requires regenerative treatments
Taiwanese should be mindful when visiting China, as Beijing in July is likely to tighten the implementation of policies on national security following the introduction of two regulations, a researcher said on Saturday. China on Friday unveiled the regulations governing the law enforcement and judicial activities of national security agencies. They would help crack down on “illegal” and “criminal” activities that Beijing considers to be endangering national security, according to reports by China’s state media. The definition of what constitutes a national security threat in China is vague, Taiwan Thinktank researcher Wu Se-chih (吳瑟致) said. The two procedural regulations are to provide Chinese